Declarations:
Acknowledgements: N/A
Conflicts of interest/Competing interests:  The authors report no conflict of interest regarding this study.
Funding: This study did not receive financial support
Informed Consent: All participants were informed about the objectives of the study and signed informed consent forms.
Availability of data and material:  All data used in this study are included in the manuscript.
REFERENCES
1. Crystal E, Connolly SJ. Atrial fibrillation: guiding lessons from epidemiology. Cardiology clinics. 2004;22(1):1-8.
2. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. Acc/aha/esc 2006 guidelines for the management of patients with atrial fibrillation: A report of the american college of cardiology/american heart association task force on practice guidelines and the european society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): Developed in collaboration with the european heart rhythm association and the heart rhythm society. Circulation. 2006;114(7):e257-e354.
3. Members ATF, Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association. European heart journal. 2012;33(21):2719-47.
4. Kato T, Yamashita T, Sagara K, Iinuma H, Fu L-T. Progressive nature of paroxysmal atrial fibrillation. Circulation Journal. 2004;68(6):568-72.
5. Fujiki A. Progression of atrial fibrillation from paroxysmal to persistent. Circulation Journal. 2014;78(5):1058-60.
6. Wyse DG, Gersh BJ. Atrial fibrillation: a perspective: thinking inside and outside the box. Circulation. 2004;109(25):3089-95.
7. Wyse D, Waldo A, DiMarco J, Domanski M, Rosenberg Y, Schron E et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management I. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825-33.
8. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New England Journal of Medicine. 2002;347(23):1834-40.
9. Hsu L-F, Jaïs P, Sanders P, Garrigue S, Hocini M, Sacher F et al. Catheter ablation for atrial fibrillation in congestive heart failure. New England Journal of Medicine. 2004;351(23):2373-83.
10. Khan MN, Jaïs P, Cummings J, Di Biase L, Sanders P, Martin DO et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. New England Journal of Medicine. 2008;359(17):1778-85.
11. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. Jama. 2010;303(4):333-40.
12. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. Journal of the American College of Cardiology. 2006;48(11):2340-7.
13. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Erratum: Guidelines for the management of atrial fibrillation (European Heart Journal (2010) 31 (2369-2429)). European Heart Journal. 2011;32(9):1172.
14. Calkins H, Brugada J, Packer DL, Cappato R, Chen S-A, Crijns HJ et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace. 2007;9(6):335-79.
15. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular research. 2002;54(2):230-46.
16. Shiroshita-Takeshita A, Brundel BJ, Nattel S. Atrial fibrillation: basic mechanisms, remodeling and triggers. Journal of Interventional Cardiac Electrophysiology. 2005;13(3):181-93.
17. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes Jr DR, Ilstrup DM et al. The natural history of lone atrial fibrillation. New England Journal of Medicine. 1987;317(11):669-74.
18. Haissaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine. 1998;339(10):659-66.
19. Rein AJ, O’Donnell CP, Colan SD, Marx GR. Tissue velocity Doppler assessment of atrial and ventricular electromechanical coupling and atrioventricular time intervals in normal subjects. The American journal of cardiology. 2003;92(11):1347-50.
20. Deniz A, Yavuz B, Ciftci O. Left atrial conduction time detected by tissue Doppler imaging increases in paroxysmal atrial fibrillation patients. Clin Cardiol. 2006;29(suppl):III-27.
21. Ausma J, Wijffels M, Thoné F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation. 1997;96(9):3157-63.
22. Platonov P, Yuan S, Hertervig E, Kongstad O, Roijer A, Vygovsky A et al. Further evidence of localized posterior interatrial conduction delay in lone paroxysmal atrial fibrillation. EP Europace. 2001;3(2):100-7.
23. Simpson Jr RJ, Amara I, Foster JR, Woelfel A, Gettes LS. Thresholds, refractory periods, and conduction times of the normal and diseased human atrium. American Heart Journal. 1988;116(4):1080-90.
24. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92(7):1954-68.
25. Deniz A, Yavuz B, Aytemir K, Hayran M, Kose S, Okutucu S et al. Intra‐left atrial mechanical delay detected by tissue Doppler echocardiography can be a useful marker for paroxysmal atrial fibrillation. Echocardiography. 2009;26(7):779-84.
26. Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation. 1991;84(4):1662-8.
27. Evranos B, Aytemir K, Oto A, Okutucu S, Karakulak U, Şahiner L et al. Predictors of atrial fibrillation recurrence after atrial fibrillation ablation with cryoballoon. Cardiology journal. 2013;20(3):294-303.
28. Wilhelm M, Kirste W, Kuly S, Amann K, Neuhuber W, Weyand M et al. Atrial distribution of connexin 40 and 43 in patients with intermittent, persistent, and postoperative atrial fibrillation. Heart, Lung and Circulation. 2006;15(1):30-7.
29. Fisher JD, Spinelli MA, Mookherjee D, Krumerman AK, Palma EC. Atrial fibrillation ablation: reaching the mainstream. Pacing and clinical electrophysiology. 2006;29(5):523-37.
30. Cappato R, Calkins H, Chen S-A, Davies W, Iesaka Y, Kalman J et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100-5.
31. Burstein B, Qi X-Y, Yeh Y-H, Calderone A, Nattel S. Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovascular research. 2007;76(3):442-52.
32. Curtis AB, Narasimha D. Arrhythmias in women. Clinical cardiology. 2012;35(3):166-71.
TABLES
Table 1. Basal echocardiographic findings of the patients.